B cells in head and neck squamous cell carcinoma: current opinion and novel therapy
Abstract Head and neck squamous cell carcinoma (HNSCC) is a common malignant tumour. Despite advancements in surgery, radiotherapy and chemotherapy, which have improved the prognosis of most patients, a subset of patients with poor prognoses still exist due to loss of surgical opportunities, postope...
Main Authors: | Xinyue Guo, Licheng Xu, Luan Nie, Chenyu Zhang, Yaohui Liu, Rui Zhao, Jing Cao, Linli Tian, Ming Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-024-03218-3 |
Similar Items
-
TMErisk score: A tumor microenvironment-based model for predicting prognosis and immunotherapy in patients with head and neck squamous cell carcinoma
by: Yu Li, et al.
Published: (2024-06-01) -
Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma
by: Yaoxu Li, et al.
Published: (2023-02-01) -
Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
by: Changyu Zhu, et al.
Published: (2025-01-01) -
Prognostic biomarker SPP1 in head and neck squamous cell carcinoma
by: Linghan Meng, et al.
Published: (2023-12-01) -
Prognostic biomarker RASSF1 in head and neck squamous cell carcinoma
by: Yishimei Si, et al.
Published: (2023-10-01)